All companies
J Pharma Co Ltd
520AIPO Upcoming
IPO UpcomingJapan(JPX Growth)Best valuation —0 markets
Official IPO
Priced· JPX Growth· Listing market: JapanPriced
Mar 25, 2026
Final price
$5.49
Shares offered
—
Raise
—
Sources: jpx
No quoted sources for this company yet.
About J Pharma Co Ltd
J Pharma Co Ltd is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
J Pharma Co Ltd belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.